Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2041 AL 2055

Traditional Chinese exercises for the treatment of neuropsychiatric symptoms in Parkinson's disease: A systematic review and meta-analysis

Tan W, Pan Z, He J, Wu T, Wu F, Xu Y, Liu L, Yang Z, Li C, Hu Y, Liao M.

Complement Ther Med. 2025 May;89:103134. doi: 10.1016/j.ctim.2025.103134. Epub 2025 Jan 20.

Fast micrographia and frontal lobe dysfunction post-traumatic brain injury: insights into pacing impairment and rehabilitation strategy

Fukui J, Yamaga T, Anmoto N, Inagaki A.

BMJ Case Rep. 2025 Jan 21;18(1):e262065. doi: 10.1136/bcr-2024-262065.

Digital health technologies and self-efficacy in Parkinson's: a scoping review

Hall AM, Allgar V, Carroll CB, Meinert E.

BMJ Open. 2025 Jan 21;15(1):e088616. doi: 10.1136/bmjopen-2024-088616.

Autoimmune Atypical Parkinsonism: A 10 year follow up of the original cohort

Kumar SS, Kannoth S, Nambiar V, Gopinath S, Anandakuttan A, Umesh SU, Unnikrishnan G, Thevarkalam M, Mathai A, Rangaswamy UK, Sudhakar A.

Neurol Sci. 2025 Apr;46(4):1883-1890. doi: 10.1007/s10072-025-07995-1. Epub 2025 Jan 23.

Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors

Yousef O, Abouelmagd ME, Abbas A, Elrosasy A, Shbani A, Raslan AM.

Neurosurg Rev. 2025 Jan 23;48(1):73. doi: 10.1007/s10143-025-03206-9.

Effects of exercise training on nigrostriatal neuroprotection in Parkinson's disease: a systematic review

Ishaq S, Shah IA, Lee SD, Wu BT.

Front Neurosci. 2025 Jan 8;18:1464168. doi: 10.3389/fnins.2024.1464168. eCollection 2024.

A PARK7 Mutation-Induced Early-Onset Parkinson's Disease in a Moroccan Family: Expanding the Geographic Spectrum

El Otmani H, Tesson C, Brice A, Lesage S.

Mov Disord Clin Pract. 2025 May;12(5):648-652. doi: 10.1002/mdc3.14339. Epub 2025 Jan 23.

"Methyl jasmonate: bridging plant defense mechanisms and human therapeutics"

Sharma G, Badruddeen, Akhtar J, Khan MI, Ahmad M, Sharma PK.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6429-6451. doi: 10.1007/s00210-024-03752-x. Epub 2025 Jan 23.

Impact of diabetes mellitus type two on incidence and progression of Parkinson's disease: a systematic review of longitudinal patient cohorts

Stockmann O, Ye L, Greten S, Chemodanow D, Wegner F, Klietz M.

J Neural Transm (Vienna). 2025 May;132(5):627-635. doi: 10.1007/s00702-025-02882-7. Epub 2025 Jan 23.

Parkinson's disease and deep brain stimulation of the subthalamic nucleus (STN-DBS): long-term disease evaluation and neuropsychological outcomes in a 9-year matched-controlled study

Cabrera-Montes J, Sanz-Arranz A, Hernandez-Vicente J, Lara-Almunia M.

Neurosurg Rev. 2025 Jan 23;48(1):74. doi: 10.1007/s10143-025-03231-8.

Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease

Vale TC, Santos DP, Oliveira DS, Paula Brandão PR, Pereira DA, Bouça-Machado R, Silva LO, Mello Rieder CR, Barbosa ER, Cury RG, Parmera JB, Ghizoni Teive HA, Ferreira MG, Ferraz HB, Candeias da Silva C, Tumas V, Nunes Cunha AL, Braga-Neto P, Lima DP, Della Colleta MV, Maia D, de Souza Fontana M, Damas CN, Lobo PP, Rebordão L, Magalhães AD, Peralta AR, Simões RM, Lampreia T, Velon AG, Carneiro D, Raimundo R, Gago M, Mendes A, Chã NV, Damásio J, Costa S, Lopes R, Morgadinho A, Mestre T, Stebbins GT, Luo S, Goetz CG, Ferreira JJ, Cardoso F; MDS-NMS Portuguese Validation Study Group.

Parkinsonism Relat Disord. 2025 Mar;132:107276. doi: 10.1016/j.parkreldis.2025.107276. Epub 2025 Jan 13.

Clinical benefits and risks of remote patient monitoring: an overview and assessment of methodological rigour of systematic reviews for selected patient groups

Wartenberg C, Elden H, Frerichs M, Jivegård LL, Magnusson K, Mourtzinis G, Nyström O, Quitz K, Sjöland H, Svanberg T, Vallo Hult H.

BMC Health Serv Res. 2025 Jan 23;25(1):133. doi: 10.1186/s12913-025-12292-w.

Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions

Kuo G, Kumbhar R, Blair W, Dawson VL, Dawson TM, Mao X.

Mol Neurodegener. 2025 Jan 23;20(1):10. doi: 10.1186/s13024-025-00797-1.

Beyond Dopamine: Novel Therapeutic Pathways for Parkinson's Disease Through Receptor Signaling

Bhushan R, Goel F, Singh S.

CNS Neurol Disord Drug Targets. 2025;24(6):434-451. doi: 10.2174/0118715273325667241212041540.

Identification of Cognitive Training for Individuals with Parkinson's Disease: A Systematic Review

Gattoni MF, Gobbo S, Feroldi S, Salvatore A, Navarro J, Sorbi S, Saibene FL.

Brain Sci. 2025 Jan 11;15(1):61. doi: 10.3390/brainsci15010061.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias